Compare INMD & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMD | NAVI |
|---|---|---|
| Founded | 2008 | 1973 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 760.4M |
| IPO Year | 2018 | 2014 |
| Metric | INMD | NAVI |
|---|---|---|
| Price | $15.19 | $9.29 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 5 | 6 |
| Target Price | ★ $17.33 | $10.00 |
| AVG Volume (30 Days) | 498.2K | ★ 1.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $271,000,000.00 |
| Revenue This Year | $1.74 | $76.23 |
| Revenue Next Year | $3.26 | $15.73 |
| P/E Ratio | ★ $10.11 | $20.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.72 | $7.33 |
| 52 Week High | $16.74 | $13.87 |
| Indicator | INMD | NAVI |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 58.50 |
| Support Level | $14.94 | $7.91 |
| Resistance Level | $15.23 | $9.68 |
| Average True Range (ATR) | 0.26 | 0.41 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 38.64 | 81.75 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.